Quarterly report pursuant to Section 13 or 15(d)

CONDENSED ONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.19.2
CONDENSED ONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended
Jul. 31, 2019
Jul. 31, 2018
Income Statement [Abstract]    
Revenue $ 0 $ 0
Operating Expenses:    
Research and development costs 72,330 267,794
Compensation expense 453,194 417,190
Director fees 75,642 81,130
Legal and professional fees 110,157 147,636
General and administrative 422,752 301,613
Total operating expenses 1,134,075 1,215,363
Loss from operations (1,134,075) (1,215,363)
Net loss $ (1,134,075) $ (1,215,363)
Basic and diluted loss per share $ (0.00) $ (0.00)
Weighted average shares outstanding basic and diluted 1,210,305,834 1,045,496,430